Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform
Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
drug advertising
drug development
fda regulations
glp-1 drugs
hims & hers
injectable wegovy
legal dispute
novo nordisk
oral wegovy
ozempic
pharmaceuticalcompanies
semaglutide
telehealth
wegovy
weight loss medication
Sanofi India Shares Fall 4% After Weak December Quarter Earnings
Shares of Sanofi India Ltd. declined sharply at the opening bell on Thursday, February 16, falling as much as 4% after the company reported weak financial performance for the December quarter.Net Profit Drops 32% Year on Year
For...